research BRAF Inhibitor Dabrafenib in Patients with Metastatic BRAF-Mutant Thyroid Cancer
Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.
Umuarama, PR, Brazil
Málaga, Andalucia, Spain
Belo Horizonte, MG, Brazil
Belo Horizonte, MG, Brazil
Gonzales, LA, United States
Houston, TX, United States